日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Temporary treatment cessation compared with continuation of tyrosine kinase inhibitors for adults with renal cancer: the STAR non-inferiority RCT

肾癌成人患者暂时停用酪氨酸激酶抑制剂与继续使用酪氨酸激酶抑制剂的疗效比较:STAR非劣效性随机对照试验

Collinson, Fiona; Royle, Kara-Louise; Swain, Jayne; Ralph, Christy; Maraveyas, Anthony; Eisen, Tim; Nathan, Paul; Jones, Robert; Meads, David; Min Wah, Tze; Martin, Adam; Bestall, Janine; Kelly-Morland, Christian; Linsley, Christopher; Oughton, Jamie; Chan, Kevin; Theodoulou, Elisavet; Arias-Pinilla, Gustavo; Kwan, Amy; Daverede, Luis; Handforth, Catherine; Trainor, Sebastian; Salawu, Abdulazeez; McCabe, Christopher; Goh, Vicky; Buckley, David; Hewison, Jenny; Gregory, Walter; Selby, Peter; Brown, Julia; Brown, Janet

Therapeutic Application of Monoclonal Antibodies in Pancreatic Cancer: Advances, Challenges and Future Opportunities

单克隆抗体在胰腺癌治疗中的应用:进展、挑战和未来机遇

Gustavo A Arias-Pinilla, Helmout Modjtahedi

Development and application of two novel monoclonal antibodies against overexpressed CD26 and integrin α3 in human pancreatic cancer

两种新型抗胰腺癌高表达 CD26 和整合素 α3 单克隆抗体的开发及应用

Gustavo A Arias-Pinilla, Angus G Dalgleish, Satvinder Mudan, Izhar Bagwan, Anthony J Walker, Helmout Modjtahedi

Development of novel monoclonal antibodies against CD109 overexpressed in human pancreatic cancer

针对人类胰腺癌中过表达的 CD109 的新型单克隆抗体的开发

Gustavo A Arias-Pinilla, Angus G Dalgleish, Satvinder Mudan, Izhar Bagwan, Anthony J Walker, Helmout Modjtahedi